Quarter Financials

Hyloris Pharmaceuticals SA (HYL.BR)

13.9 €

-0.08 (-0.57%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2022 Q2 2021 Q4 2021 Q2 2020 Q2 2020 Q1
Net Income ----2-2
Dividend Paid -----
Retained Earnings -60-55-51-40-38

PPE Schedule

Year 2022 Q2 2021 Q4 2021 Q2 2020 Q2 2020 Q1
Capital Expenditure ----0-0
Net PPE 00000

Intangible and Goodwill Schedule

Year 2022 Q2 2021 Q4 2021 Q2 2020 Q2 2020 Q1
New Purchases -----
Intangible and Goodwill -----